GKWIM
ONC

Gerber Kawasaki Wealth & Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-110
Closed -$39K – 1163
2021
Q3 		$39K Buy
+110
New +$36K 0.01% 357

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's ONC Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of BeOne Medicines Ltd (ONC) in Q4 2021, closing a stake of 110 shares — an estimated $39K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in ONC in Q3 2021 and held it in 1 quarter. The position peaked at $39K in Q3 2021. 263 funds tracked by Wall St. Rank hold ONC as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining BeOne Medicines Ltd position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 110 BeOne Medicines Ltd shares in Q4 2021, an estimated $39K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in BeOne Medicines Ltd in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's BeOne Medicines Ltd position peaked at $39K in Q3 2021.
  • 263 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.